Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of rotation from subcutaneous to transdermal fentanyl in hospitalized cancer pain patients
NL-OMON26606Recruiting
- Sponsor
- Erasmus MC
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fentanyl in cancer pain, sponsored by Erasmus MC. Primary endpoint: Bioequivalence in fentanyl exposure pre- and post-rotation. Started Nov 2021; status: recruiting.
02
Drugs
fentanyl
03
Conditions
cancer pain
Beyond the preview
Go deeper on NL-OMON26606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26606.